
1. expert opin biol ther. 2017 nov;17(11):1375-1387. doi:
10.1080/14712598.2017.1364359. epub 2017 aug 10.

systemic virotherapy multiple myeloma.

oliva s(1), gambella m(1), boccadoro m(1), bringhen s(1).

author information: 
(1)a myeloma unit, division hematology , university torino, azienda
ospedaliero-universitaria citt√† della salute e della scienza di torino , torino ,
italy.

introduction: multiple myeloma (mm) treatment scenario changed
considerably past years. several novel targeted therapies are
currently consideration including oncolytic virotherapy. areas covered:
this review provides analysis mechanisms action virotherapy, 
summarizes preclinical clinical studies systemic virotherapy developed
for treatment mm. different types viruses identified,
including: adenovirus, vaccinia virus, herpes simplex virus 1, myxoma virus,
reovirus, measles virus, vesicular stomatitis virus coxsackievirus a21.
expert opinion: above-mentioned viruses simply infect and
kill malignant plasma cells alone combination chemo and/or
radiotherapy. fact, also used purge myeloma cells 
an autologous bone marrow (bm) transplant. investigations required to
better explore best therapeutic combinations mm also overcome
antiviral response immunity limit efficacy therapeutic
strategy.

doi: 10.1080/14712598.2017.1364359 
pmid: 28796556  [indexed medline]

